EKB Journal Management System

1.

Inflammatory Biomarkers as Prognostic and Predictive Factor in Patients with COVID-19

Volume 34, Issue 3, July 2025, Pages 401-406
Wafaa F. Hamad; Radhia H. Fadel

2.

Comparison of the Medical Costs of Cured and Dead COVID-19 Patients in the Intensive Care Units of a Fever Hospital

Volume 99, Issue 1, April 2025, Pages 2055-2064

3.

Efficacy Of Tocilizumab On Critical Intensive Care Unit COVID-19 Patients: Retrospective Study Among Egyptian Armed Forces Hospitals.

Volume 1, Issue 1, December 2023, Pages 65-73
Mahmoud Khaled Hussien; Marwa Saad Fathi; Fatma Mostafa Mahmoud; Raafat Zaher Abdelrahman; Mohamed Abd El-Salam El-Gohary; Ahmed Gad Taha

4.

Significance of IL10 in COVID-19 Patients

Volume 90, Issue 1, January 2023, Pages 1356-1364
Doaa Ezzat Mohamed Elbarbary; Mona Mohamed Watany; Mohamed Samir Abd Elghafar; Manal Abd Elwahed Eid

5.

The Effect of Co-Infection of Coronavirus with Hepatitis B

Volume 14, Issue 2, December 2022, Pages 185-191
Huda Dakeel Ali,; Asma Easa Mahmood; Batol Imran Dheeb

6.

Effect of combined use of ivermectin and colchicine in COVID-19 patients

Volume 38, Issue 1, December 2022, Pages 365-372
Rania Gamal El Sayed; Amr Fouad Hafez; Adham Magdy Ahmed Mohammed Haggag; Mohamed A. Alhadidy

7.

TNF-a and IL-10 Serum Levels in COVID-19 Patients and their Relation to Disease Severity

Volume 90, Issue 9, September 2022, Pages 1459-1467
HEND H. TAMIM, M.D.; MAI A. SALEH, M.Sc.; SAMEH A. AL-DAWY, M.D.; MARAWAN M. EL TOUKHY, M.D.; HEBA M. SELIM, M.D.

8.

Diagnostic Value of Serum Level of Interleukin 33 (IL-33), C-C Motif Chemokine Ligand 17 (CCL17) and Interferon Gamma Inducible Protein-10 (IP-10) in Coronavirus Disease 2019 (COVID-19) Patients

Volume 31, Issue 1, January 2022, Pages 23-30
Nouran Magdy Moustafa; Rania A. Mohamed; Rania G. Elsaid; Fatma M. Mahmoud

9.

Interferon- gamma-induced protein-10 (IP-10) serum level and natural killer cell count as predictive factors for the severity of COVID-19

Volume 2, Issue 4, November 2021, Pages 623-631
Mai Mustafa Mounir Yasin; Riham El-Asady; Nesma Gamal Ahmed Elsheikh; Manal Mohammed Mokhtar

10.

The Predictors of Cardio-renal Syndrome among Patients with ‎COVID-19 Infection‎ ‎

Volume 11, Issue 1, March 2021, Pages 51-60
Aber Halim Baki; Hazem Mansour; Ahmed Tareq Elkhouly; Osama Mohamad Farrag

11.

COVID-19; Immunology, pathology, severity and immunosuppressants

Volume 1, Issue 1, January 2021, Pages 1-12
Mennat-Allah Safwat; Ayman Reda Abdul-Rahman; Hagar Fathy Forsan; Rihan Abduljabar; Omnia Riad

12.

Correlating COVID-19 Infection Severity and Prognosis with Cytokines Level

Volume 30, Issue 1, January 2021, Pages 93-99
Essraa Aly Hegazy

13.

Standpoints on immune responses against COVID-19

Volume 6, Issue 3, September 2020, Pages 150-160
Mabrouk A. Abo-Zaid; Ahmed H. Ismail; Ali H Amin

14.

Enhancement of immune tolerance of COVID-19 patients might be achieved with alginate supplemented therapy

Volume 4, Special Issue, June 2020, Pages 21-26
Amany El-Sekaily; Mohamed Helal; Aziza Saad

15.

CYCLOSPORIN H: A NOVEL ANTI-INFLAMMATORY THERAPY FOR INFLUENZA FLU PATIENTS

Volume 47, Issue 1, April 2017, Pages 25-33
SALWA A. ELGEBALY; TAMER ELBAYOUMI; DONALD L. KREUTZER